Dougald Monroe, PhD, professor of medicine in the Division of Hematology and the UNC Blood Research Center, co-authored an article with Ammon Fager, MD, PhD, assistant professor of medicine at Duke University titled, “Stopping the bleed when platelets don’t stick” in Nature Cardiovascular Medicine.
The commentary discusses a novel bifunctional antibody that brings factor VIIa to the surface of activated platelets. The bifunctional antibody is in clinical trials for treatment of the platelet adhesion disorder called Glanzmann thrombasthenia.